News

A large prospective study published in Molecular Nutrition and Food Research reveals that a healthy plant-based diet is ...
A large prospective study published in Molecular Nutrition and Food Research reveals that a healthy plant-based diet is linked with a reduced risk ...
Eli Lilly announced an update on its Phase 3 clinical study testing Mirikizumab for pediatric Crohn’s disease, showing real ...
Crohn’s disease affects the digestive tract, but patients may also experience extraintestinal manifestations (EIMs) or complications. This refers to complications outside of the intestines.
Mirikizumab significantly improves fatigue among adults with moderately to severely active Crohn disease during both induction and maintenance therapy.
Patients with inflammatory bowel disease may be twice as likely to develop rheumatoid arthritis than those without IBD.